1. Introduction
Vision deterioration due to glaucoma is a worldwide growing issue. It is estimated that 3% of people over 40 years of age suffer from glaucoma, and this percentage increases several times with age [
1]. The extension of life expectancy means that a larger number of glaucoma patients may experience visual field disorders and the resulting dysfunctions in everyday activities. This condition, characterised by retinal ganglion cell (RGC) degeneration and subsequent optic nerve damage, leads to irreversible visual field (VF) loss [
2,
3]. While traditional treatments focus on lowering intraocular pressure (IOP), glaucomatous damage can progress despite IOP reduction, highlighting the importance of understanding the vascular theory of glaucomatous optic neuropathy (GON) [
4]. This theory, proposed by Flammer, suggests that impaired ocular blood flow and retinal microvascular autoregulation contribute to the development and progression of the disease [
5]. Impaired RGCs require reduced blood supply, causing retinal arteriolar constriction, which has been found even in preperimetric glaucoma [
6]. The eye’s microvasculature is unique and can be non-invasively and directly visualised, imaged, and quantified. The integrity and function of the retinal tissue depend on adequate perfusion in the microcirculatory network [
7,
8].
Fluctuation of blood flow and poor ocular perfusion in glaucoma patients correlate with visual field deterioration [
7,
8]. Glaucoma diagnosis is based on a combination of correlated glaucomatous optic nerve head and visual field defects analyses, followed by monitoring their progression. VF tests are subjective and cannot detect early signs of GON progression. Optical coherence tomography (OCT) examination, including assessment of the peri-papillary retinal nerve fibre layer (RNFL) thickness and the ganglion cell complex (GCC), is the gold standard for evaluating structural changes in the optic nerve head (ONH) due to glaucoma (GON) earlier than in perimetric tests. Both perimetry and OCT are crucial but may not detect the earliest stages of glaucoma [
9,
10]. Newer imaging techniques offer more objective and detailed insights into retinal microcirculation. Techniques of retinal image analysis, especially static retinal vessel analysis (SRVA), have enabled the objective and accurate measurement of retinal vascular calibre with high reproducibility for detecting signs of retinopathy.
In contrast, the scanning laser Doppler flowmetry (SLDF) or dynamic retinal vessel analysis of retinal vascular diameter in response to flickering light allows the examination of dynamic aspects of retinal microcirculation [
11]. Another new method of measuring the size of small arterioles is adaptive optics (AO). AO enables noninvasive retinal examination at the cellular level with a resolution of approximately two micrometres by measuring wavefront distortions and compensating them in real-time with deformable mirrors [
12,
13]. AO technology can be incorporated into imaging devices, such as fundus cameras, optical coherence tomography (OCT), or scanning laser ophthalmoscopy (SLO) [
12,
13]. Rtx1™ is a commercially available AO-fundus camera (AO-FC) that uses infrared light (850 nm wavelength) and is characterised by a resolution of 1.6 μm. The image dimensions are 4∘ × 4∘, representing 1.2 mm × 1.2 mm of the retina. Image acquisition lasts approximately 4 s, during which 40 individual images are acquired [
13]. SLDF and AO can estimate the wall and lumen thickness, as well as the wall-to-internal diameter ratio (also known as the wall-to-lumen ratio, WLR) of retinal arterioles.
Development in OCT systems has enabled the noninvasive measurement of retinal vasculature at the optic disc head, peripapillary area, and in the macular region by determining the dynamic motion of red blood cells in a flowing blood vessel [
14,
15,
16]. This diagnostic technique, introduced in 2016, is known as optical coherence tomography angiography (OCTA) [
14]. OCTA images are made by repeating B-scans over the same tissue location, two or more times. Changes in the OCT signal in subsequent scans, caused by the movement of red blood cells or other particles, generate the angiographic contrast with the stable signal from the vessel walls. OCTA devices create a static map of the vascular capillary networks [
16]. OCTA can stratify the circulation into inner and deep capillary plexuses [
14,
15,
16]. The superficial network comprises vessels that surround and nourish the nerve fibre and ganglion cell layers. The thickness of this capillary network is significantly greater near the ONH than in other regions of the retina, owing to the increased thickness of the RNFL [
16]. Peripapillary capillaries arise from arterioles around the optic disc, have few anastomoses and are very sensitive to IOP fluctuations [
16].
Reduced perfusion in the optic nerve head, peripapillary retina, and even the macula has been detected in glaucoma patients using various devices. OCTA has been used to analyse the area of peripapillary microcirculation in glaucoma patients and has demonstrated strong diagnostic accuracy, repeatability, and reproducibility [
17,
18,
19,
20,
21].
The present study aimed to evaluate the parameters of retinal arterioles using rtx1™ AO-FC and peripapillary and macular vessel densities in eyes with OCTA with primary open-angle glaucoma (POAG) different stages compared to healthy eyes. Secondly, the associations between these vascular parameters and glaucoma severity, as defined by structural changes in OCT and functional changes in the VF test, have been investigated, along with comparisons with results in healthy eyes. This study is the first trial to analyse retinal microcirculation with two modern noninvasive methods in correlation with structural and functional tests in POAG.
2. Materials and Methods
The study was performed between July and September 2022 at the Department of Ophthalmology, Faculty of Medicine, the Medical University of Warsaw, in the Ophthalmic Public Hospital in Warsaw. The Bioethical Commission for the Medical University of Warsaw approved the study protocol (approval number KB/87/2015). All investigations were conducted by the principles of the Helsinki Declaration. After the presentation of the study protocol, all participants signed an informed consent form.
Subjects: We included 57 eyes from 31 patients with primary open-angle glaucoma (POAG), recruited from the Glaucoma Department at our hospital, and 50 eyes from 25 healthy volunteers. The patients included in the study had been diagnosed with bilateral primary open-angle glaucoma (POAG), with assessment of retinal nerve fibre layer (RNFL), ganglion cell complex (GCC) defects, and optic nerve head (ONH) parameters using optical coherence tomography (OCT), multifocal electroretinography (MD), and pattern standard deviation (PSD) in perimetry. Glaucoma was diagnosed at least two years ago. Glaucoma in each eye was staged as early-1A - pre-perimetric glaucoma: no visual field scotoma in perimetry (16 eyes); moderate- 1B early perimetric glaucoma (24 eyes); or severe- 1C – moderate perimetric glaucoma: (17 eyes) using the criteria of simplified Hodapp’s classification [
3].
Patients from the control group had an IOP of less than 21 mmHg and a normal appearance of the ONH, RNFL, and GCC parameters, all within normal ranges, as determined by OCT. All subjects were above 18 years old and were of white European descent.
We excluded eyes with refractive errors > 6 D or cylindrical lens ≥ 2,5 D; axial eye length ≥ 26 mm, distance best corrected visual acuity (BCVA) ≤ 0,4 on Snellen charts, media opacities resulting in low image qualities, diabetes mellitus, history of trauma or any other ocular diseases which may influence on retinal vessels morphology.
Study protocol
Demographic data, including age, weight, height, and a history of general diseases (hypertension, diabetes, ischemic heart disease, or stroke), were obtained from questionnaires completed by the participants. We checked the systolic and diastolic blood pressures (SBP, DBP) in the sitting position on the brachial artery.
The full ophthalmic examination, including best-corrected visual acuity (BCVA), refractometry, slit lamp biomicroscopy, Goldmann applanation tonometry, gonioscopy, and direct fundoscopy was performed. Axial eye length was acquired using IOL Master 700 (Carl Zeiss Meditec AG, Hennigsdorf, Germany). The RNFL, GCC thickness, and rim area were assessed using spectral domain optical coherence tomography (SD-OCT) with the RTVue XR 100 Avanti Edition (Optovue Inc., Fremont, CA, USA).
Humphrey 24.2 sita-standard visual field with the reliability indices of the European Glaucoma Society was performed on Humphrey Field Analyzer 3 (Zeiss, Germany).
AO fundus images were obtained using AO-FC (Rtx1™; Imagine Eyes, Orsay, France– version 3.4) with AO Detect Artery software to analyse retinal vessel parameters [
6]. Examinations were done without pupil dilation. Images of a superior and inferior temporal retinal artery were obtained. The following parameters were assessed: lumen diameter (LD), wall thickness (WT), and total diameter (TD), which was calculated as the sum of single WT and LD. Single WT: TD = WT + (WT + LD) was used when evaluating vessel morphology. The following two parameters, wall-to-lumen ratio (WLR) and cross-sectional area of the vascular wall (WCSA), were automatically obtained from the AO artery detection software. WLR is the ratio of the vessel's WT to LD, calculated as 2 × WT ÷ LD, while WCSA describes the relationship between LD and TD. All the above-mentioned retinal parameters were measured three times on the scan with the best quality; the arithmetic mean of these three values was used in the statistical analysis. Angio-OCT (OCTA) images were obtained using spectral optical tomography (SD-OCT) (REVO NX, software version 11.07, Optopol Technology, Zawiercie, Poland) with an angio-OCT option. The REVO NX is characterised by a light source of 850 nm wavelength and 50 nm bandwidth (half-bandwidth) utilising SLED technology. It operates at a scanning speed of 130,000 measurements per second, achieving a digital axial resolution of 2.8 μm and 5.0 μm within the tissue. The transverse resolution is 12 μm, with a typical value of 18 μm. Macular vasculature was evaluated on 6x6 mm scans of the Superficial and Deep Plexus Capillary (SCP, DCP). The measurement zones included the following regions: total (entire measurement area), superior (upper half of the measurement area), inferior (lower half of the measurement area), centre (central ring with a diameter of 1 mm), and the combined area (ETDRS) of three concentric rings with diameters of 1, 3, and 6 mm. Additionally, the foveal avascular zone (FAZ) was evaluated within the Superficial and Deep Plexus of the macula in semi-automatic mode.
The following parameters were assessed: FAZ area in mm², perimeter of the FAZ area in mm, and circularity of the FAZ area (the ratio of the measured perimeter to the circumference of a circular area of the same size). 4 × 4 mm angio-OCT images assessed the ONH vascularisation. Quantitative measurements (the density map) were performed within the radial peripapillary capillary plexus (RPCP) in total (entire measurement area), superior (upper half of the measurement area), and inferior (lower half of the measurement area) regions. REVO's real-time hardware eye-tracking feature compensated for blinking, loss of focus, and unintentional eye movements during OCT scanning [
22]. Only a few patients required manual scanning after multiple attempts in automatic mode. Dilating the pupils was unnecessary to obtain an optimal-quality image.
Statistical Analyses
The data analysis was conducted with Statistica™ v. 13.2, TIBCO Software Inc., Palo Alto, CA, USA; 2017. For continuous variables, the presented means with their standard deviations (SD) were compared between the POAG and control groups using either the Student’s t-test or the Mann-Whitney U-test, depending on the data distribution. The Shapiro-Wilk test was used to determine the normality of each continuous variable. The Kruskal-Wallis and chi-square tests were used to compare at least three groups on a quantitative variable. Relationships between numerical variables were assessed using Pearson correlation analysis when the data met parametric conditions for a parametric test, and Spearman correlation analysis when they did not. A two-sided test was applied for p-values, and statistical significance was defined as a p-value of less than 0.05.
3. Results
Glaucoma vs. Healthy Eyes
Significant differences existed between the control (healthy) and glaucoma groups in terms of best-corrected visual acuity (BCVA) and intraocular pressure (IOP). There were no differences between groups in age (
p = 0.067), systolic and diastolic blood pressure (SBP,
p = 0.117; DBP,
p = 0.069), and BMI (
p = 0.069). Patients with glaucoma had lower distance BCVA (0.998 vs 0.895 for the healthy and glaucomatous groups, respectively,
p < 0.001) and lower IOP values (15.08 vs 13.2 in the healthy and glaucomatous groups, respectively,
p < 0.001). There has been a similar percentage of patients suffering from arterial hypertension (HA) (
p = 0.896) or coronary heart disease (CHD) (
p = 0.346) between study groups. Mean diastolic systemic blood pressure (DBP) was not significantly lower in the glaucoma group (80.5 vs 77.7 for healthy and glaucomatous groups;
p = 0.069). Significant differences, confirming the group classification, were found in all analysed OCT parameters: mean RNFL, mean GCC, and VC/D ratio (p < 0.001). The results are presented in
Table 1.
The glaucoma groups were compared regarding OCT parameters (mean RNFL, vertical c/d ratio, mean GCC, and rim area), visual field parameters (mean deviation (MD) and pattern standard deviation (PSD)), retinal artery parameters in AO Rtx1™, and OCTA measurements.
Table 2 evaluates the OCT parameters, including rim area, RNFL, GCC, and vc/d, in three glaucoma groups. There were significant differences among all glaucoma subgroups, depending on the severity of the disease. The RNFL thickness, as well as the average thickness in the superior and inferior quadrants, rim area, and average GCC thickness, have progressively decreased with the advancement of optic nerve damage. The values of the vertical c/d ratio increased.
Comparison of AO Rtx1™ Arteriolar Parameters Between Glaucoma and Healthy Eyes
All analysed arteriole parameters, except the mean WCSA of the inferior artery, have shown significant differences between healthy and glaucoma eyes. The wall thicknesses (WT1, WT2) were significantly higher in eyes with glaucoma than in the control group. Because the mean lumen diameter (LD) values were significantly smaller in all glaucoma groups than in comparison to the control group, it turned out the increased values of the WLR ratio in Glaucoma group (for the supratemporal artery 0.301 vs 0.238 for glaucomatous and healthy groups, respectively) and for infratemporal artery 0.308 vs 0.241 glaucomatous for and healthy groups respectively (
p < 0.001). The mean total diameter (TD) values were significantly smaller in glaucoma eyes compared to healthy eyes (
p < 0.001) (
Table 4).
The perimetry test results also changed with the progression of glaucoma, starting from MD and PSD values within normal limits in group Glaucoma A to their values in the Glaucoma C group, which classified the eyes as severely damaged in the Hodapp classification. The results are presented in
Table 3.
Correlation Analysis of Supratemporal Retinal Arteriole Parameters in POAG Group
The following AO rtx1™ arteriolar parameters did not show statistically significant differences between glaucoma groups: vessel wall thickness, total diameter, and WCSA for the supratemporal (
p > 0.05) and infratemporal (
p > 0.05) retinal arterioles. Decreasing the mean supratemporal artery lumen was observed with the progression of GON, but it was not found in the inferior localisation of the analysed artery. WLR did not differ significantly between glaucoma groups, but the mean values were slightly higher in groups Glaucoma B and Glaucoma C compared to Glaucoma A (
Table 5).
Table 4.
AO-rtx1™ parameters in control (healthy) and glaucoma groups.
Table 4.
AO-rtx1™ parameters in control (healthy) and glaucoma groups.
| AO−rtx1™ Parameters |
Control Group |
Glaucoma Group |
p-Value *
|
| TDm S (m ± SD) (µm) |
124.1 ± 12.4 |
111.0 ± 10.4 |
<0.001†
|
| LDm S (m ± SD) (µm) |
100.6 ± 11.1 |
85.5 ± 10.4 |
<0.001†
|
| 1WTm S (m ± SD) (µm) |
12.2 ± 1.3 |
12.8 ± 1.4 |
0.030 |
| 2WTm S (m ± SD) (µm) |
11.6 ± 1.2 |
12.6 ± 1.2 |
<0.001†
|
| WLRm S (m ± SD) |
0.238 ± 0.002 |
0.301 ± 0.04 |
<0.001 |
| WCSAm S (m ± SD) (µm2) |
4197.3 ± 657.9 |
3909.5 ± 531.6 |
0.019†
|
| TDm I (m ± SD) (µm) |
124.4 ± 12.0 |
114.4 ± 11.0 |
<0.001†
|
| LDm I (m ± SD) (µm) |
100.4 ± 10.9 |
87.7 ± 10.8 |
<0.001†
|
| 1WTm I (m ± SD) (µm) |
12.1 ± 1.3 |
13.4 ± 1.8 |
<0.001 |
| 2WTm I (m ± SD) (µm) |
11.9 ± 1.1 |
13.3 ± 1.74 |
<0.001 |
| WLRm I (m ± SD) |
0.241 ± 0.021 |
0.308 ± 0.047 |
<0.001 |
| WCSAm I (m ± SD) (µm2) |
4245.6 ± 690.9 |
4257.5 ± 812.1 |
0.937 |
Table 5.
AO-rtx1™ parameters in 3 glaucoma groups.
Table 5.
AO-rtx1™ parameters in 3 glaucoma groups.
| AO−rtx1™ Parameters |
Group A |
Group B |
Group C |
p-Value †
|
| total number of eyes |
16 |
24 |
17 |
|
| TDm S (m ± SD) (µm) |
113.1 ± 11.8 |
111.6 ± 10.2 |
109.4 ± 8.7 |
0.384 |
| LDm S (m ± SD) (µm) |
87.8 ± 11.3 |
85.8 ± 10.2 |
84.0 ± 9.5 |
0.416 |
| 1WTm S (m ± SD) (µm) |
12.9 ± 1.7 |
12.9 ± 1.3 |
12.5 ± 1.1 |
0.225 |
| 2WTm S (m ± SD) (µm) |
12.5 ± 1.4 |
12.7 ± 1.2 |
12.5 ± 1.2 |
0.867 |
| WLRm S (m ± SD) |
0.293 ± 0.043 |
0.304 ± 0.048 |
0.301 ± 0.041 |
0.744 |
| WCSAm S (m ± SD) (µm2) |
3982.5 ± 657.3 |
3971.2 ± 500.3 |
3808.0 ± 394.2 |
0.539 |
| TDm I (m ± SD) (µm) |
113.2 ± 10.6 |
116.1 ± 12.2 |
112.7 ± 14.0 |
0.595 |
| LDm I (m ± SD) (µm) |
87.7 ± 9.5 |
89.3 ± 11.3 |
85.8 ± 12.2 |
0.558 |
| 1WTm I (m ± SD) (µm) |
13.0 ± 1.6 |
13.4 ± 2.2 |
13.6 ± 1.5 |
0.506 |
| 2WTm I (m ± SD) (µm) |
13.0 ± 1.8 |
13.5 ± 1.8 |
13.2 ± 1.6 |
0.503 |
| WLRm I (m ± SD) |
0.302 ± 0.042 |
0.306 ± 0.057 |
0.316 ± 0.040 |
0.656 |
| WCSAm I (m ± SD) (µm2) |
4114.3 ± 746.1 |
4349.1 ± 838.6 |
4218.9 ± 910.7 |
0.584 |
Comparison of OCTA Parameters Between Glaucoma and Healthy Eyes
Both total, superior and inferior Superficial Plexus Capillary (SCP) densities in the macula region were significantly lower in the glaucoma group comparing to the control group. In comparison, significant differences in total and inferior Deep Plexus Capillary (DPC) macular densities were found between groups. The density in the superior DCP was lower in glaucomatous eyes; however, the difference was not statistically significant (p = 0.073). The combined area (ETDRS) of three concentric rings of 1, 3, and 6 mm diameters was significantly lower in the superficial plexus and not significantly in the deep plexus in glaucoma eyes (p < 0.001 for SCP ETDRS; p = 0.09 for DCP ETDRS).
Additionally, the foveal avascular zone (FAZ) was evaluated within the superficial and deep plexus of the macula, and it was found to be significantly larger in eyes with glaucoma compared to those of healthy individuals. Other parameters assessed in the FAZ also showed significant differences between groups: the perimeter of the FAZ area was enlarged in the glaucoma group in SCP and DCP, and the circularity of the FAZ area was lower in the glaucoma group.
Quantitative measurements of the ONH’s vascularisation were performed within the radial peripapillary capillary plexus (RPCP). Compared to the control group, eyes with glaucoma had significantly lower peripapillary vessel densities in all analysed regions: total, superior, and inferior (
p < 0.001) (
Table 6).
Comparison of OCTA Parameters Between Glaucoma Groups
The SCP macular densities were higher in eyes with early glaucoma (Group Glaucoma A) compared to Groups Glaucoma B and Glaucoma C, which had mild and severe glaucomatous optic neuropathy (GON), respectively. Significant differences were observed in total and inferior SCP macular densities between glaucoma eyes (
p = 0.014,
p = 0.004, respectively). There were no differences in the DCP macular densities between glaucoma subgroups, regardless of the disease stages. The FAZ in the superficial plexus did not differ between groups Glaucoma A and Glaucoma C. Still, a non-significant difference was found in the deep plexus in the mentioned subgroups. The vascularisation around the ONH (RPCP) was the highest in eyes with early glaucoma and decreased significantly in groups Glaucoma B and Glaucoma C in all analysed regions (
Table 7).
Correlations of the OCTA Results with Other Analysed Parameters
A negative correlation was found between SCP values and systolic SBP and diastolic DBP blood pressures in healthy eyes, with respective correlation coefficients of r = -0.432 and r = -0.340. A similar relationship was not found in any of the subgroups of glaucomatous eyes. In the control group, no other correlations were found between the SCP and DCP values, OCT parameters (RNFL, rim area, VC/D, and GCC), and arteriole parameters in AO Rtx1™.
In glaucoma eyes, SCP macular density was positively correlated with OCT parameters (RNFL, r = 0.621; GCC, r = 0.536; rim area, r = 0.489) and VF parameters (MD, r = 0.426), and negatively correlated with PSD, as indicated by WLR from AO rtx1™ (r = -0.517). This suggests better structural and functional integrity is associated with higher SCP density. In the whole glaucoma group, there were positive correlations between SCP and vessel size (TD) (r = 0.471), vessel lumen (LD) (r = 0.494), and vessel surface area (WCSA) (r = 0.342), and a negative correlation with WLR (r = -0.476) in AO rtx1™.
A positive and significant correlation was observed between SCP macular density and RNFL in the glaucoma subgroups A and B (r = 0.680 in both). However, it did not occur in the C group, which consisted of eyes with advanced glaucoma. Glaucoma subgroups B and C also demonstrated a negative correlation of SCP macular density with WLR (respectively r = -0.530 and r = -0.518) in AO rtx1™. Subgroup C showed a positive correlation between SCP and LD in AO rtx1™ (r = 0.521).
The correlation analysis of DCP macular density in glaucomatous eyes revealed a positive relationship with OCT parameters, specifically RNFL (r = 0.387), rim area (r = 0.335), and GCC (r = 0.390). Still, no correlation was found between the parameters of the visual field and the retinal arteries in AO rtx1™.
Assessment of the Correlation of the RPCP
The density of the RPCP in healthy and glaucomatous eyes was positively correlated with diastolic blood pressure (r = 0.432). RPCP density in glaucoma eyes correlated positively with RNFL (r = 0.334) and GCC thickness (r = 0.457) in OCT, and MD (r = 0.480) in VF, and negatively with PSD (r = -0.375) in VF and arterial wall thickness (r = -0,489) from AO rtx1™. The analysis of individual subgroups of glaucomatous eyes confirmed a negative correlation between the thickness of the retinal artery wall in AO rtx1™ and RPCP in Glaucoma B (r = -0.567). Positive correlations with OCT and MD in VF for eyes with advanced glaucomatous damage (Glaucoma C) (r = 0.722).
4. Discussion
Glaucoma is a chronic neuropathy in which RGCs die, causing irreversible defects in the visual field [
2]. According to the vascular theory of glaucoma development, retinal microcirculation disorders play a very important role in both the pathogenesis and progression of GON [
5,
6,
7]. Impaired blood flow in the optic nerve ONH and retina in glaucoma patients is well-documented [
7,
8,
17,
18,
19,
20,
21,
23,
24,
25,
26,
27].
Our study, published in 2024 in JCM, is significant as it revealed changes in retinal vessels, using adaptive optics, in eyes with very early glaucoma, a stage previously difficult to detect without visual field defects. This finding, unique to our study, underscores the importance of analysing the relationship between retinal microcirculation disorders and the severity of functional and structural changes during glaucoma. Some studies have investigated the relationship between retinal microcirculation disorders and the severity of glaucoma. However, our study is the first to evaluate two modern non-invasive imaging methods, OCTA and AO rtx1™, for retinal microcirculation analysis, which could have significant implications for glaucoma diagnosis and monitoring.
Our study employed a comprehensive approach, comparing patients with different stages of glaucoma (GON) with a control group of healthy eyes, and within the glaucoma group, depending on the disease progression. We also performed a correlation analysis of the changes in retinal microcirculation with parameters illustrating structural (OCT) and functional (VF) damage in glaucoma, providing a thorough and reliable set of results.
OCTA and AO are powerful complementary techniques that have fundamentally changed retinal and optic nerve head (ONH) imaging. They enable the routine visualisation of structures with cellular resolution in either cross-sectional or en-face views. OCTA allows visualisation of the density of superficial and deep vascular plexuses. At the same time, AO enables the determination of all structural parameters of retinal small arterioles, as it can distinguish the vessel walls and lumen from the blood column. This method distinguishes between the functional vasoconstriction of an arteriole and the structural remodelling of a vessel.
AO rtx1™
Significant differences were found in all analysed retinal arterioles’ parameters in AO between glaucoma and healthy eyes. AO imaging revealed early structural changes in retinal arterioles, such as narrowing, wall thickening and increased WLR, even in pre-perimetric glaucoma. Previously, the narrowing of retinal arterioles in POAG has been demonstrated in several studies [
13,
27,
28,
29,
30,
31]. Our study’s results were similar to those of Hugo et al., who were the first to use AO to evaluate the retinal vasculature in glaucoma and found a significant reduction in TD and LD in POAG patients compared to healthy individuals [
32]. While vessel wall thickness and total diameter did not differ significantly between glaucoma stages, a trend of decreasing artery lumen was observed with GON progression.
WLR was significantly higher in all examined eyes with glaucoma; its values increased slightly with progression of GON. The reduction in vessel calibre and lumen in more severe glaucoma ONH damage was not accompanied by an increase in the thickness of the arterial walls. This may indicate a lack of hypertrophy, a characteristic of hypertensive retinopathy [
33]. Signs typical for eutrophic remodelling, characterised by an increased WLR and reduced LD due to arterioles vasoconstriction [
33], were found in our study. It was also confirmed by the lower average WCSA in the entire group of eyes with glaucoma compared to the control group. This parameter indicates the vessel’s surface area and increases in vascular diseases associated with thickening and hypertrophy of the blood vessel walls, e.g., arterial hypertension or diabetes [
33].
OCTA: SCP, DCP, RPCP, FAZ
OCTA demonstrated reductions in microvascular density in the macular and peripapillary regions, correlating with the severity of glaucoma and functional loss. Enlarged FAZ areas indicate ischemic microvascular changes in glaucoma. Our results are consistent with other studies that analyse retinal vessel density using angio-OCT in glaucomatous eyes [
17,
18,
19,
20,
21,
25,
26]. Studies using noninvasive techniques, such as Laser Doppler flowmetry and laser speckle flowgraphy, also confirmed lower blood flow on the entire optic disc in glaucoma eyes [
23,
24]. The SCP macular densities were higher in eyes with early glaucoma (group A) compared to eyes with mild and severe GON. There were no differences in the DCP macular densities between glaucoma subgroups, regardless of the disease stages. The vascularisation around the ONH (RPCP) was highest in eyes with early glaucoma and decreased significantly in groups B and C in all analysed regions. Enlarged FAZ areas indicate ischemic microvascular changes in glaucoma, and we observed a correlation between these areas and disease severity. FAZ area has been implicated in pathological processes like diabetic retinopathy [
34,
35]. Enlarged FAZ areas have also been described in glaucoma eyes, exhibiting a similar diagnostic value for glaucoma as conventional structural parameters analysed in OCT (RNFL and GCC thickness) [
34,
36,
37,
38].
The enlarged FAZ area in glaucoma eyes ranged from 0.360 to 0.435 mm², depending on the type of OCTA machine, segmentation method, and image analysis approach [
36,
37,
38]. In our study, which examined only Caucasian patients, the mean FAZ area was 0.295 and 0.546 mm² for healthy and glaucoma eyes, respectively—a value even slightly higher than that reported in earlier studies for the Asian population. Kwon et al. reported an enlarged FAZ area, which correlated with VF defects in patients with glaucoma [
37,
38]. They presented results consistent with ours, showing that an enlarged FAZ area was also found in glaucomatous eyes without visual field defects [
38]. Shoji et al. found that IOP reduction after glaucoma surgery improved perifoveal microcirculation and decreased FAZ area up to 3 months postoperatively [
34]. Their results support the hypothesis of RGC-function reversibility with IOP reduction [
34]. They concluded that OCTA-derived FAZ metrics may be biomarkers for RGC activity and visual function [
34].
SCP Correlations with OCT and VF, AO rtx1™
There were positive correlations in glaucoma eyes between SCP macular density and OCT parameters (RNFL, GCC, rim area) and VF (MD), and negative correlations with PSD. Thicker RNFL, GCC, and larger rim areas were found in eyes with higher SCP density. In the analysis of individual subgroups of eyes with glaucoma, a positive correlation was observed between SCP density and RNFL in OCT only in eyes with early and moderate glaucoma, but not in eyes with advanced glaucoma. It may indicate a lower demand for nutrients and capillary vascularisation in retinal areas with RGC damage. Similar to our results, Rao et al. demonstrated that macular vessel density in the parafoveal region was reduced as measured in patients with glaucoma compared to healthy eyes [
39]. Shoji et al. suggested that changes in macular vessel density may be used for monitoring GON progression [
40]. On the other hand, Rao et al. postulated that macular vessel density has moderate diagnostic performance, which is poorer than that of measurements in the peripapillary region, in differentiating glaucoma eyes from healthy eyes. Their study included individuals with pre-perimetric and early glaucoma whose foveal region remains intact, which could be responsible for the poorer diagnostic accuracy of macular vessel density measurements [
39].
Yarmohammadi et al. demonstrated that vessel densities in both the peripapillary and macular regions were significantly lower in the eyes of patients with POAG and unilateral visual field loss compared to healthy eyes of a similar age [
41]. The peripapillary vessel density in the eyes with VF defect was lower than in their fellow unaffected eyes. In contrast, the difference in macular vessel density was similar in both eyes of the same patient [
41]. In another work published in 2017, the authors reported that deterioration of peripapillary and macular vessel density was also found in perimetrically intact glaucomatous eyes [
42]. This finding is consistent with our results, which show significantly lower vessel density measurements even in eyes without detectable visual field (VF) damage in early glaucoma. Another similarity in our study concerned OCT parameters, including RNFL, rim area, and mGCC, which were significantly lower even in glaucomatous eyes without visual field defects than in healthy eyes [
41]. Larger SCP macular densities corresponded with larger arteriole lumen and total diameters, and lower WLR in AO rtx1™. DCP densities correlated only with OCT parameters, not AO-measured arteriole parameters.
RPCP Correlations with BP, OCT, VF, AO rtx1™
RPCP density positively correlated with RNFL, GCC in OCT, and VF MD; negatively correlated with VF PSD and arteriole wall thickness in AO rtx1™.
A correlation between reduced RPCP density and structural and functional glaucoma defects has also been found in other studies [
17,
18,
19,
20,
21]. Wang et al. reported that decreased disc flow index and peripapillary vessel density in glaucomatous eyes correlated with the severity of glaucoma damage [
21]. The RNFL primarily comprises the axons of RGCs and has high metabolic requirements that depend on regional capillary networks running parallel to the RGC axons [
18]. Akagi et al. suggested that peripapillary microvascular reduction may occur after retinal nerve fibre layer (RNFL) thinning [
19]. Still, other authors found lower retinal capillary perfusion even before the apoptotic death of defective retinal ganglion cells (RGC) [
20,
21]. Yarmohammadi et al. found that capillary vessel density has comparable diagnostic accuracy to RNFL thickness in OCT scans for detecting glaucoma and glaucoma suspects [
25]. They did not classify glaucoma eyes for GON advancement as we did. The mean VF parameters (MD: -3.9 dB (-8.8, 1.8)) and PSD: 4.6 dB (2.7, 8.9)) and average RNFL thickness (74.5 (72.1-76.9)) allow patients to be classified as having early and mild GON (25). In our work, we divided the eyes of glaucoma patients into three subgroups, ranging from early pre-perimetric glaucoma to those with severe defects in OCT and visual field (VF) tests. Quantitative measurements of the vascularisation of the ONH showed significantly lower values in all analysed regions in all glaucoma subgroups.
The VF MD correlates more strongly with peripapillary vessel density than with RNFL thickness or rim area, suggesting that vascular perfusion may correlate more closely with visual function [
20]. In the Yospon study, the correlation between VF parameters and RPCP was moderate to good [
43].
Yospon et al. also reported significantly lower peripapillary vessel densities in eyes with severe glaucoma than in those with early and moderate glaucoma. Their values were strongly correlated with average RNFL thickness but only moderately related to GCC, as these parameters are measured in different anatomical areas [
43]. Our study showed no significant differences between superior and inferior RPCP localisations. It decreased vessel densities in the group with early glaucoma (Glaucoma A) compared to the subsequent subgroups, but without differences between Glaucoma B and Glaucoma C.
In the correlation analysis of two retinal vessel imaging methods, AO rtx1™ and OCTA, higher SCP densities were correlated with wider arterial vessels (TD), larger vessel lumens (LD), and lower WLR coefficients. In eyes with reduced SCP density, higher WLR values were found. In the eyes of the group Glaucoma C, reduced SCP density was also correlated with narrowing of the arterial lumen. These findings suggest a strong relation between the superficial capillary plexus and the morphology of small retinal arterioles.
5. Limitations
Due to the study’s non-interventional design, it was not possible to evaluate the potentially confounding impact of ocular hypotensive eye drops and blood pressure-lowering medications on vascular measurements. It is also worth noting that, in the present study, patients were not excluded based on systemic conditions or medications to better reflect the general population. Further studies are needed to address the influence of ocular hypotensive treatment and systemic medications on OCTA and AO rtx1™ measurements. Larger, longitudinal studies are required to clarify and validate these imaging biomarkers.
6. Conclusions
This study confirms that vascular alterations in retinal arterioles and capillary plexuses are associated with the pathophysiology and progression of glaucoma. Our results support the concept of vascular deterioration in glaucoma, where vascular changes may precede structural abnormalities in the optic nerve head (ONH). Reduced retinal vessel densities in the macular and peripapillary regions, as well as narrowing of retinal arterioles, correlate with structural loss and visual field defects in glaucomatous eyes. Enlarged FAZ areas indicate ischemic microvascular changes in glaucoma. These data suggest that both OCTA and AO rtx1™ measurements show a very good correlation with the severity of glaucoma, allowing for the discrimination of eyes with glaucoma from healthy eyes earlier than in typical diagnostic glaucoma tests. They may be useful tools in the early diagnosis, staging, and monitoring of patients with glaucoma, as well as in identifying eyes at high risk before irreversible damage occurs. The combined use of AO rtx1™ and OCTA provides complementary and detailed insights into retinal microcirculation, surpassing the limitations of traditional imaging.
Supplementary Materials
The following supporting information can be downloaded at the website of this paper posted on Preprints.org.
Author Contributions
Conceptualisation, A.Z.-Ż.; A.S. and Z.M.W.; methodology, A.S., Z.M.W. and A.Z.-Ż.; validation, Z.M.W.; formal analysis, A.S., A.Z.-Ż. and Z.M.W.; investigation, A.S., M. Ż and A.Z.-Ż.; writing—original draft preparation, A.Z.-Ż.; writing—review and editing, A.S., A.Z.-Ż., Z.M.W. and J.P.S. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
This study was conducted according to the Declaration of Helsinki and was approved by the Ethics Committee of the Medical University of Warsaw (KB/87/2015; 07.04.2025).
Informed Consent Statement
Informed consent was obtained from all subjects involved in this study. Written informed consent to publish this paper was obtained from the patients.
Data Availability Statement
The data are not publicly available due to privacy.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 2081. [CrossRef] [PubMed]
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA, 1901. [CrossRef]
- Martucci, A.; Nucci, C.; Pinazo-Duran, M.D. Editorial: New perspectives in glaucoma pathophysiology, diagnosis, and treatment. Front. Med. 2023, 10, 1200427. [Google Scholar] [CrossRef] [PubMed]
- Shalaby WS, Ahmed OM, Waisbourd M, Katz LJ. A review of potential novel glaucoma therapeutic options independent of intraocular pressure. Surv Ophthalmol, 1062. [CrossRef] [PubMed]
- Flammer, J. The vascular concept of glaucoma. Surv Ophthalmol. S: (Suppl 3). [CrossRef]
- Szewczuk A, Wawrzyniak ZM, Szaflik JP, Zaleska-Żmijewska A. Is Primary Open-Angle Glaucoma a Vascular Disease? Assessment of the Relationship between Retinal Arteriolar Morphology and Glaucoma Severity Using Adaptive Optics. J Clin Med. 4: 15;13(2). [CrossRef] [PubMed] [PubMed Central]
- Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. [CrossRef]
- Deokule S, Vizzeri G, Boehm A, Bowd C, Weinreb RN. Association of visual field severity and parapapillary retinal blood flow in open-angle glaucoma. J Glaucoma. [CrossRef]
- Kuang TM, Zhang C, Zangwill LM, Weinreb RN, Medeiros FA. Estimating lead time gained by optical coherence tomography in detecting glaucoma before the development of visual field defects. Ophthalmology, 2002. [CrossRef]
- Chang RT, Singh K. Glaucoma suspect: diagnosis suspect: diagnosis and management. J Ophthalmol. [CrossRef]
- Ikram MK, Ong YT, Cheung CY, Wong TY. Retinal vascular calibre measurements: clinical significance, current knowledge and future perspectives. Ophthalmologica. [CrossRef] [PubMed]
- Akyol E, Hagag AM, Sivaprasad S, et al. Adaptive optics: principles and applications in ophthalmology. Eye. [CrossRef]
- Szewczuk A, Zaleska-Żmijewska A, Dziedziak J, Szaflik JP. Clinical Application of Adaptive Optics Imaging in Diagnosis, Management, and Monitoring of Ophthalmological Diseases: A Narrative Review. Med Sci Monit, e: 4;29, 9419. [CrossRef] [PubMed] [PubMed Central]
- Rao HL, Pradhan ZS, Suh MH, Moghimi S, Mansouri K, Weinreb RN. Optical coherence tomography angiography in glaucoma. J Glaucoma. [CrossRef]
- Van Melkebeke L, Barbosa-Breda J, Huygens M, Stalmans I. Optical coherence tomography angiography in glaucoma: a review. Ophthalmic Res. [CrossRef]
- Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, Shi Y, Wang RK. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 6: 60. [CrossRef] [PubMed] [PubMed Central]
- Liu L, Jia Y, Takusagawa HL, Pechauer AD, Edmunds B, Lombardi L, Davis E, Morrison JC, Huang D. Optical Coherence Tomography Angiography of the Peripapillary Retina in Glaucoma. JAMA Ophthalmol, 2: [PubMed, 1045.
- Chen CL, Zhang A, Bojikian KD, Wen JC, Zhang Q, Xin C, Mudumbai RC, Johnstone MA, Chen PP, Wang RK. Peripapillary Retinal Nerve Fiber Layer Vascular Microcirculation in Glaucoma Using Optical Coherence Tomography-Based Microangiography. Invest Ophthalmol Vis Sci, 2: 57(9): Oct47 5–485. [PubMed, 2744.
- Akagi T, Iida Y, Nakanishi H, Terada N, Morooka S, Yamada H, Hasegawa T, Yokota S, Yoshikawa M, Yoshimura N. Microvascular Density in Glaucomatous Eyes With Hemifield Visual Field Defects: An Optical Coherence Tomography Angiography Study. Am J Ophthalmol, 2: 249. [PubMed, 2729.
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Yousefi S, Saunders LJ, Belghith A, Manalastas PI, Medeiros FA, Weinreb RN. Relationship between Optical Coherence Tomography Angiography Vessel Density and Severity of Visual Field Loss in Glaucoma. Ophthalmology, 2: 123(12):2498–2508. [PubMed, 2498.
- Wang X, Jiang C, Ko T, et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Arch Clin Exp Ophthalmol, 1557. [CrossRef]
- https://optopol.
- Hamard P, Hamard H, Dufaux J, Quesnot S. Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open-angle glaucoma and normal pressure glaucoma. Br J Ophthalmol.
- Michelson G, Langhans MJ, Groh MJ. Perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open angle glaucoma. J Glaucoma.
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, et al. Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes. Ophthalmol Vis Sci. [CrossRef]
- Jia Y, Wei E, Wang X et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 1322.
- Jonas JB, Nguyen XN, Naumann GO. Parapapillary retinal vessel diameter in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci, 1: 30, 1599.
- Wang, S.; Xu, L.; Wang, Y.; Wang, Y.; Jonas, J.B. Retinal vessel diameter in normal and glaucomatous eyes: The Beijing eye study. Clin. Exp. Ophthalmol. 2007, 35, 800–807. [Google Scholar] [CrossRef] [PubMed]
- Jonas JB, Nguyen XN, Gusek GC, Naumann GO. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci.
- Rader, J.; Feuer, W.J.; Anderson, D.R. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Arch. Ophthalmol. 1994, 117, 72–80. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Q.; Jan, C.; Guo, C.Y.; Wang, F.H.; Liang, Y.B.; Cao, K.; Zhang, Z.; Yang, D.Y.; Thomas, R.; Wang, N.L.; et al. Association of intraocular pressure-related factors and retinal vessel diameter with optic disc rim area in subjects with and without primary open angle glaucoma. Clin. Exp. Ophthalmol. 2018, 46, 389–399. [Google Scholar] [CrossRef] [PubMed]
- Hugo, J.; Chavane, F.; Beylerian, M.; Callet, M.; Denis, D.; Matonti, F. Morphologic Analysis of Peripapillary Retinal Arteriole Using Adaptive Optics in Primary Open-angle Glaucoma. Eur. J. Gastroenterol. Hepatol. 2020, 29, 271–275. [Google Scholar] [CrossRef] [PubMed]
- Meixner, E.; Michelson, G. Measurement of retinal wall-to-lumen ratio by adaptive optics retinal camera: A clinical research. Graefe’s Arch. Clin. Exp. Ophthalmol. 2015, 253, 1985–1995. [Google Scholar] [CrossRef] [PubMed]
- Shoji T, Kanno J, Weinreb RN, Yoshikawa Y, Mine I, Ishii H, Ibuki H, Shinoda K. OCT angiography measured changes in the foveal avascular zone area after glaucoma surgery. Br J Ophthalmol. [CrossRef] [PubMed] [PubMed Central]
- Tang FY, Ng DS, Lam A, et al. Determinants of quantitative optical coherence tomography angiography metrics in patients with diabetes. Sci Rep, 2575.
- Choi J, Kwon J, Shin JW, Lee J, Lee S, Kook MS. Quantitative optical coherence tomography angiography of macular vascular structure and foveal avascular zone in glaucoma. PLoS One, e: 12, 0184.
- Kwon J, Choi J, Shin JW, Lee J, Kook MS. Glaucoma diagnostic capabilities of foveal avascular zone parameters using optical coherence tomography angiography according to visual field defect location. J Glaucoma. 1120.
- Kwon J, Choi J, Shin JW, Lee J, Kook MS. An Optical Coherence Tomography Angiography Study of the Relationship Between Foveal Avascular Zone Size and Retinal Vessel Density. Invest Ophthalmol Vis Sci, 4: 1;59(10), 4143. [CrossRef] [PubMed]
- Rao HL, Pradhan ZS, Weinreb RN, et al. Regional comparisons of optical coherence tomography angiography vessel density in primary open angle glaucoma. Am J Ophthalmol, 7: 171.
- Shoji T, Zangwill LM, Akagi T, et al. Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study. Am J Ophthalmol, 1: 182.
- Yarmohammadi A, Zangwill LM, Manalastas PIC, Fuller NJ, Diniz-Filho A, Saunders LJ, Suh MH, Hasenstab K, Weinreb RN. Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss. Ophthalmology. [CrossRef] [PubMed] [PubMed Central]
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, et al. Peripapillary and Macular Vessel Density in Patients with Glaucoma and Single-Hemifield Visual Field Defect. Ophthalmology. 2017. [CrossRef]
- Yospon T, Rojananuangnit K. Optical Coherence Tomography Angiography (OCTA) Differences in Vessel Perfusion Density and Flux Index of the Optic Nerve and Peri-Papillary Area in Healthy, Glaucoma Suspect and Glaucomatous Eyes. Clin Ophthalmol, 3: 12; 17, 3011. [CrossRef] [PubMed] [PubMed Central]
Table 1.
Demographic and OCT parameters in healthy (control group) and glaucoma groups.
Table 1.
Demographic and OCT parameters in healthy (control group) and glaucoma groups.
| Parameters |
Control Group |
Glaucoma Group |
p-Value *
|
| age (m ± SD) (years) |
49.5 ± 4.4 |
51.7 ± 6.4 |
0.067 |
| HA |
8.3% |
9.8% |
0.896 |
| CHD |
4.2% |
14.8% |
0.346 |
| BMI (m ± SD) (kg/m2) |
23.7 ± 2.1 |
24.4 ± 1.8 |
0.069 |
| SBP (m ± SD) (cm Hg) |
123.4 ± 11.2 |
127.5 ± 10.1 |
0.117 |
| DBP (m ± SD) (cm Hg) |
80.5 ± 9.2 |
77.7 ± 7.1 |
0.069 |
| BCVA (m ± SD) |
0.998 ± 0.014 |
0.895 ± 0.142 |
<0.001 |
| IOP (m ± SD) (cm Hg) |
15.1 ± 2.5 |
13.2 ± 2.7 |
<0.001†
|
| AL (m ± SD) (mm) |
23.8 ± 0.8 |
24.0 ± 1.2 |
0.683 |
| OCT c/d v (m ± SD) |
0.501 ± 0.153 |
0.811 ± 0.118 |
<0.001 |
| OCT RNFL (m ± SD) (µm) |
101.3 ± 7.4 |
78.8 ± 13.9 |
<0.001 |
| OCT GCC (m ± SD) (µm)
|
97.7 ± 4.8 |
80.74 ± 11.8 |
<0.001 |
Table 2.
OCT parameters (Rim area, RNFL, GCC, and vc/d) in 3 glaucoma groups.
Table 2.
OCT parameters (Rim area, RNFL, GCC, and vc/d) in 3 glaucoma groups.
| OCT Parameters |
Group A |
Group B |
Group C |
p-Value †
|
| total number of eyes |
16 |
24 |
17 |
|
| RIM AREA (m ± SD) |
0.854 ± 0.304 |
0.824 ± 0.324 |
0.492† ± 0.146 (p < 0.001) |
<0.001 |
| Vertical Cup-to-disc ratio (m ± SD) |
0.556 ± 0.051 |
0.596 ± 0.021 |
0.863†± 0.806 (p < 0.001) |
<0.001 |
| RNFL average (m ± SD) (µm)
|
88.6 ± 11.4 |
82.1 ± 10.7 |
65.3† ± 10.7 (p < 0.001) |
<0.001 |
| RNFL superior (m ± SD) (µm)
|
88.7 ± 13.7 |
84.1 ± 14.0 |
68.3† ± 13.5 (p = 0.004) |
<0.001 |
| RNFL inferior (m ± SD) (µm)
|
89.1 ± 11.2 |
80.1 ± 10.1 |
62.1† ± 9.7 (p < 0.001) |
<0.001 |
| GCC (m ± SD) (µm)
|
90.0 ± 8.8 |
83.0 ± 9.4 |
68.8† ± 8.2 (p < 0.001) |
<0.001 |
Table 3.
Perimetry tests parameters for MD and PSD in 3 glaucoma groups.
Table 3.
Perimetry tests parameters for MD and PSD in 3 glaucoma groups.
| Visual Field Parameters |
Group A |
Group B |
Group C |
p-Value *
|
| total number of eyes |
16 |
24 |
17 |
|
| MD (m ± SD) (dB) |
−0.17 ± 0.91 |
−1.89 ± 1.49 |
−13.55 ± 7.66 (p† < 0.001; p†† = 0.014) |
<0.001 |
| PSD (m ± SD) (dB) |
1.56 ± 0.25 |
3.55 ± 2.04 |
10.30± 3.75 (p† < 0.001) |
<0.001 |
Table 6.
OCTA parameters in healthy (control) and glaucoma groups.
Table 6.
OCTA parameters in healthy (control) and glaucoma groups.
| OCTA Parameters |
Control Group |
Glaucoma Group |
p-Value *
|
| SCP FAZ (mm²) |
0.295 ± 0.125 |
0.546 ± 0.299 |
<0.001 |
| SCP perimeter (mm) |
2.006 ± 0.497 |
3.444 ± 1.494 |
<0.001 |
| SCP circularity |
0.700 ± 0.082 |
0.555 ± 0.159 |
<0.001 |
| DCP FAZ (mm²) |
0.430 ± 0.172 |
0.651 ± 0.303 |
<0.001 |
| DCP perimeter (mm) |
2.394 ± 0.471 |
3.342 ± 0.896 |
<0.001 |
| DCP circularity |
0.716 ± 0.072 |
0.591 ± 0.122 |
<0.001 |
| SCP Total |
38.61 ± 1.31 |
36.78 ± 1.85 |
<0.001 |
| SCP Super |
38.76 ± 1.17 |
36.91 ± 1.84 |
<0.001 |
| SCP Infer |
38.40 ± 2.06 |
36.63 ± 2.63 |
<0.001 |
| SCP Etdrs |
38.46 ± 1.41 |
36.39 ± 3.60 |
<0.001 |
| DCP Total |
41.06 ± 1.21 |
40.17 ± 2.54 |
0.024 |
| DCP Super |
41.07 ± 1.21 |
40.23 ± 2.60 |
0.073 |
| DCP Infer |
41.05 ± 1.62 |
40.10 ± 2.75 |
0.025 |
| DCP Etdrs |
41.33 ± 1.38 |
40.67 ± 2.51 |
0.090 |
| RPCP Total |
39.27 ± 1.48 |
35.42 ± 4.97 |
<0.001 |
| RPCP Super |
39.44 ± 1.17 |
35.59 ± 5.01 |
<0.001 |
| RPCP Infer |
39.03 ± 2.24 |
35.17 ± 5.14 |
<0.001 |
Table 7.
OCTA parameters in 3 glaucoma groups.
Table 7.
OCTA parameters in 3 glaucoma groups.
| OCTA Parameters |
Group A |
Group B |
Group C |
p-Value †
|
| total number of eyes |
16 |
24 |
17 |
|
| SCP FAZ (mm²) |
0.564 ± 0.356 |
0.449 ± 0.190 |
0.566 ± 0.289 |
0.711 |
| DCP FAZ (mm²) |
0.569 ± 0.219 |
0.588 ± 0.308 |
0.762 ± 0.344 |
0.904 |
| SCP Total |
37.9 ± 1.2 |
36.8 ± 2.2 |
36.6 ± 0.9 p††=0.011 |
0.014 |
| SCP Super |
37.7±1.4 |
36.9±2.1 |
36.7±1.4 |
0.171 |
| SCP Infer |
38.2±1.2 |
36.6±3.1 |
36.5±1.0 p††=0.004 |
0.004 |
| DCP Total |
40.7±3.2 |
39.9±3.0 |
40.5±1.0 |
0.063 |
| DCP Super |
40.6±3.3 |
40.0±3.1 |
40.3±1.3 |
0.126 |
| DCP Infer |
40.7±3.2 |
39.8±3.0 |
40.7±1.1 |
0.157 |
| RPCP Total |
37.7±0.8 |
34.3±6.6 |
34.7±4.4 p††=0.003 |
0.033 |
| RPCP Super |
37.8±1.2 |
34.2±6.7 |
34.6±4.6 p††=0.013 |
0.017 |
| RPCP Infer |
37.5±1.5 |
34.2±6.8 |
34.8±4.5 p††=0.035 |
0.041 |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).